GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SS Innovations International SSII · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.87

-11.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About SS Innovations International

From its filings with the US Securities and Exchange Commission

SEC filings

SS Innovations International is based in Gurugram and is incorporated in Florida. Its shares trade on Nasdaq under the ticker SSII. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $42.5m and a net loss of $12.1m. At that date it held total assets of $74.2m and shareholders' equity of $38.2m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
9 Jul 2018
Employees
483
Head office
405, 3RD FLOOR, ILABS INFO TECH CENTRE, GURUGRAM, 122016
Incorporated in
FL
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Dr. Sudhir SrivastavaChairman of the Board, Chief Executive Officer, since 2023$14.2m
  • Mr. Naveen AmarChief Financial Officer
  • Dr. Vishwajyoti SrivastavaChief Executive Officer, Asia Pacific, Director, since 2023$3.1m
  • Mr. Barry CohenChief Operating Officer, Americas, Director, since 2023$196,000
  • Mr. Tim AdamsIndependent Director
  • Dr. Mylswamy AnnaduraiIndependent Director
  • Dr. Frederic MollIndependent Director
  • Dr. S.P. SomashekharIndependent Director$16,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • SS Innovations International Inc has a fully autonomous medical robotic system developed with proprietary software.
  • The company's SSI Mantra surgical robotic system is a key product in its portfolio.
  • SSI Maya, a XR-based surgical robotics training and patient care platform, uses web3-based technologies for 3D holographic DICOM imaging.

Weaknesses

  • The company employs only 483 employees, which is a constraint in its operational capacity.
  • SS Innovations International Inc went public in October 2018, indicating a relatively recent IPO.
  • The company is headquartered in Orlando, Florida, limiting its geographic reach.

Opportunities

  • The development of SSI Maya with web3-based technologies presents an opportunity for innovation in surgical training platforms.
  • SSI Mudra, a range of surgical instruments, supports various surgical procedures including robotic cardiac surgery.
  • OMNI 3D HD is a robotic surgery training platform that can expand into tele-mentoring and tele-proctoring markets.

Threats

  • The company's reliance on a single product line, the SSI Mantra surgical robotic system, poses a risk to its business model.
  • SS Innovations International Inc's focus on AI and deep learning may face regulatory challenges in the health care sector.
  • The use of web3-based technologies in SSI Maya could lead to security vulnerabilities in the platform.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.